Literature DB >> 6765248

An immune response against the alloantigens of the 3LL Lewis lung carcinoma prevents the growth of lung metastases, but not of local allografts.

N Isakov, M Feldman, S Segal.   

Abstract

3LL tumor cells inoculated intra footpad grow locally both in syngeneic and in allogeneic recipients. Yet, spontaneous lung metastases appear only in syngeneic animals or in mice which share with the tumor strain of origin both the D-end of the H-2b haplotype and the genetic background. The lack of lung metastases in allogeneic recipients is not due to tissue restrictions for tumor growth, since intravenous injections of tumor cells resulted in local primary lung tumors. The growth rate of primary intra footpad tumors or pulmonary tumors in syngeneic mice is similar to that in congenic resistant recombinant mice. From a local intra footpad tumor in BALB/c mice, 3LL cells migrate out and reach the lungs but are arrested there, since grafts of lungs from such mice onto (BALB/c X C57BL/6)F1 resulted in tumor growth. Since spontaneous metastases developed in chimeric (C3HeB X C57BL/6)F1----C3HeB mice, it appeared that immunogenetic restrictions prevent the growth of spontaneous 3LL metastases in allogeneic recipients. Further support for the notion of allograft rejection of lung metastases derived from experiments demonstrating the generation of metastases in nu/nu ICR mice but not in nu/+ heterozygous ICR animals. It thus appeared that the local allograft of the 3LL tumor elicits a reaction which prevents the growth of its metastases. This was further supported in experiments in which intravenous inoculation of 3LL cells to allogeneic recipients from which the local tumor was removed did not produce lung tumors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6765248

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  4 in total

1.  Lewis lung carcinoma (3LL) cells treated in vitro with ultraviolet radiation show reduced metastatic ability due to an augmented immunogenicity.

Authors:  S Peppoloni; R B Herberman; E Gorelik
Journal:  Clin Exp Metastasis       Date:  1987 Jan-Mar       Impact factor: 5.150

2.  Specific eradication of micrometastases by transfer of tumour-immune T cells from major-histocompatibility-complex congenic mice.

Authors:  V Schirrmacher; P von Hoegen; A Griesbach; H J Schild; U Zangemeister-Wittke
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

3.  Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor model.

Authors:  Ngoc H On; Ryan Mitchell; Sanjot D Savant; Corbin J Bachmeier; Grant M Hatch; Donald W Miller
Journal:  J Neurooncol       Date:  2012-11-27       Impact factor: 4.130

4.  Leukocyte, rather than tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinoma.

Authors:  Sabina Sangaletti; Antonella Stoppacciaro; Cristiana Guiducci; Maria Rosaria Torrisi; Mario P Colombo
Journal:  J Exp Med       Date:  2003-11-10       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.